[Skip to Content]
[Skip to Content Landing]
Viewpoint
May 2016

Institutional Conflict of Interest and the Translational Pathway

Author Affiliations
  • 1Duke University School of Medicine, Durham, North Carolina
 

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Ophthalmol. 2016;134(5):483-484. doi:10.1001/jamaophthalmol.2016.0459

This is an exciting era for translational research, with novel therapeutic and diagnostic approaches for a wide spectrum of diseases, including diseases of the eye. Translational research, the conversion of basic science discoveries into clinical applications, inevitably includes issues regarding the commercialization process. Since the Bayh-Dole Act of 1980, the line of demarcation between the domains of the nonprofit academic institution and the commercial world has become increasingly fuzzy. A recent case example provides an illustration of this blurring and the potential effects of institutional conflict of interest.

×